CA3153832C - Formulations otiques, procedes et dispositifs - Google Patents

Formulations otiques, procedes et dispositifs

Info

Publication number
CA3153832C
CA3153832C CA3153832A CA3153832A CA3153832C CA 3153832 C CA3153832 C CA 3153832C CA 3153832 A CA3153832 A CA 3153832A CA 3153832 A CA3153832 A CA 3153832A CA 3153832 C CA3153832 C CA 3153832C
Authority
CA
Canada
Prior art keywords
formulation
ear
cps
dexamethasone
mineral oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3153832A
Other languages
English (en)
Other versions
CA3153832A1 (fr
Inventor
Douglas I. Hepler
Gail L. Dempsey
Dorothea A. Erxleben
Neil E. Paulsen
Original Assignee
Dechra Veterinary Products LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dechra Veterinary Products LLC filed Critical Dechra Veterinary Products LLC
Priority claimed from PCT/US2020/054770 external-priority patent/WO2021072063A1/fr
Publication of CA3153832A1 publication Critical patent/CA3153832A1/fr
Application granted granted Critical
Publication of CA3153832C publication Critical patent/CA3153832C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne une formulation et un procédé de traitement d'une infection de l'oreille, en particulier l'otomycose et l'otite externe, par administration d'un traitement en une seule fois comprenant un antibiotique, un antifongique et un anti-inflammatoire dans un support otique épais. Dans un mode de réalisation, la formulation comprend une quantité thérapeutiquement efficace d'ingrédients actifs comprenant une marbofloxacine, de la terbinafine et/ou du clotrimazole et de la dexaméthasone.
CA3153832A 2019-10-11 2020-10-08 Formulations otiques, procedes et dispositifs Active CA3153832C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962914301P 2019-10-11 2019-10-11
US62/914,301 2019-10-11
PCT/US2020/054770 WO2021072063A1 (fr) 2019-10-11 2020-10-08 Formulations otiques, procédés et dispositifs

Publications (2)

Publication Number Publication Date
CA3153832A1 CA3153832A1 (fr) 2021-04-15
CA3153832C true CA3153832C (fr) 2025-10-07

Family

ID=

Similar Documents

Publication Publication Date Title
CA2862406C (fr) Formulations, procedes et dispositifs otiques
AU2026201359A1 (en) Otic formulations, methods and devices
US20210393511A1 (en) Otic gel formulations for treating otitis externa
KR20230058444A (ko) 코, 귀 및 다른 조직 감염 및/또는 염증을 치료하기 위한 조성물, 디바이스 및 방법
US12478629B2 (en) Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals
CA3153832C (fr) Formulations otiques, procedes et dispositifs
US9849126B2 (en) Sterile otic formulations
WO2014036165A1 (fr) Compositions de type aqueux pour traiter l'otite externe
US20060165755A1 (en) Method for treating otitis externa